Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 338, pseudogene (RN7SL338P)

Target
RN7SL338P
Molecular classification
Pseudogene, Non-coding RNA, Processed pseudogene
01

Overview

RN7SL338P is a pseudogene derived from the 7SL RNA gene, located on human chromosome 9. 7SL pseudogenes are typically truncated, non-coding copies dispersed throughout the human genome, formed by reverse transcription of functional 7SL RNA into DNA. While functional 7SL RNA is a key component of the signal recognition particle required for co- and post-translational protein targeting within the cell, pseudogene copies such as RN7SL338P do not encode active RNA and are generally not expressed at significant levels. Pseudogenes may have potential regulatory roles as non-coding RNAs, such as acting as competitive endogenous RNAs, but there is no established function or disease relevance attributed specifically to RN7SL338P. It is not considered a therapeutic target, and its name and annotation are correct as a pseudogene in current databases.

Other names
RN7SL338PRNA, 7SL, cytoplasmic 338, pseudogene
02

Mechanism of action

Null (no mechanisms of action for drugs targeting RN7SL338P)

03

Biological functions

Null (no direct biological function established for this specific pseudogene)By analogy with other pseudogenes, possible functions as competing endogenous RNAs (ceRNAs), miRNA sponges, or involvement in epigenetic regulation, but no supporting evidence for RN7SL338P specifically
04

Disease associations

Null (no known disease associations for RN7SL338P specifically)General role for 7SL RNA pseudogenes in disease is speculative; active 7SL RNA gene deregulation has been implicated in cancer and neurodegeneration, but not pseudogenes
05

Safety considerations

Null (no safety concerns or therapeutic challenges relevant to RN7SL338P)
06

Interacting drugs

Null (no known drugs interact with RN7SL338P)
07

Biomarkers

Null (not used as a biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 338, pseudogene (RN7SL338P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 338, pseudogene (RN7SL338P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call